Revelation Biosciences, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:REVB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 3.97 M5.4 M12.86 M11.58 M15.04 M Total liabilities 1.09 M1.57 M1.85 M2.72 M2.06 M Total equity 2.88 M3.83 M11 M8.86 M12.99 M Total liabilities & shareholders' equities 3.97 M5.4 M12.86 M11.58 M15.04 M Total debt ————— Net debt —————

News

Revolution Beauty allots 1.45 million shares under incentive plan

Revelation Biosciences to implement 1-for-4 reverse stock split

Revelation Biosciences announces warrant exercise agreement

Why Ericsson Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Ambitions Enterprise Mgmt (NASDAQ:AHMA), American Rebel Holdings (NASDAQ:AREB)

Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours? - Revelation Biosciences (NASDAQ:REVB)

Revelation Biosciences reaches FDA agreement on AKI treatment pathway

Revelation Biosciences begins GMP manufacturing for GEMINI trials

Revelation Biosciences shareholders approve warrant issuance and meeting adjournment

Revolution Beauty brings back co-founder as consultant

Revelation Biosciences submits end-of-phase 1 package to FDA

Revolution Beauty shareholders approve £16.5 million fundraise

Gemini shows promise in rebalancing inflammation for CKD patients